top of page
CLINCIAL TRIALS
-
Study of TBX-3400 in Patients With Stage III and IV Melanoma Resistant or Refractory to Immune Checkpoint Inhibitors - click here for more information
-
Study of TBX-3400 in Subjects With Solid Malignant Tumors Resistant or Refractory to Standard Therapies - click here for more information
-
Safety and Early Efficacy Study of TBX-2400 in Patients With AML or Myelofibrosis - click here for more information
bottom of page